Tempest Therapeutics, Inc. TPST

Full chart Compare
Set alert

Price alert · TPST

All alert types
0.46 USD -0.01 (-1.13%)

At closeNov 5, 2026, 4:40 AM EST

0.47 +0.01 +1.42%

Pre-market · Nov 5, 4:40 AM ET

0.4552 Day range 0.4997
0.4552 52-week range 10.33
YTD
-83.86%
1 year
-94.92%

Revenue & Expenses

Net Loss → Expenses: $82.26MExpenses → Gross Loss: $4.75MExpenses → Selling, General & Admin: $49.22MExpenses → Research & Development: $21.64MExpenses → Other Operating Expenses: $5.40MExpenses → Other Expenses: $1.05MExpenses → Income Tax: $201.00KRevenue → Cost of Revenue: $653.00KNet Loss$82.26MCost of Revenue$5.40MExpenses$82.26MGross Loss$4.75MSelling, General & Admin$49.22MResearch & Development$21.64MOther Operating Expenses$5.40MOther Expenses$1.05MIncome Tax$201.00KRevenue$653.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

TPST annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-26.57M-42.03M-29.16M-34.64M-26.99M
-26.26M-41.84M-29.49M-35.71M-28.30M
-6.33-19.50-24.80-40.20-97.00
TPST annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.71M30.27M39.23M31.23M51.83M
16.93M41.49M51.60M46.09M73.24M
10.26M22.36M24.84M27.98M37.12M
8.14M15.37M20.66M22.11M18.54M
6.67M19.13M26.77M18.11M36.12M
TPST annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-26.82M-33.03M-27.36M-31.07M-25.96M
4.26M24.50M35.60M11.40M59.06M
-22.56M-8.96M8.07M-20.23M33.01M